Inovio Pharmaceuticals, Inc. financial data

Symbol
INO on Nasdaq
Location
6769 Mesa Ridge Rd., San Diego, CA
State of incorporation
Delaware
Fiscal year end
December 31
Former names
INOVIO BIOMEDICAL CORP (to 5/11/2010), GENETRONICS BIOMEDICAL CORP (to 4/1/2005), GENETRONICS BIOMEDICAL LTD (to 8/3/2001)
Latest financial report
10-Q - Q2 2024 - Aug 8, 2024

Key Ratios

Label TTM Value / Value Unit Change %
Current Ratio 409 % +11%
Debt-to-equity 40.4 % -9.51%
Return On Assets -77.6 % -42.9%

Shares

Label TTM Value / Value Unit Change %
Entity Common Stock, Shares Outstanding 26M shares -90.3%
Common Stock, Shares, Outstanding 26M shares -90.3%
Entity Public Float 120M USD -71.9%
Common Stock, Value, Issued 26K USD -90.3%
Weighted Average Number of Shares Outstanding, Basic 27.2M shares +23.5%
Weighted Average Number of Shares Outstanding, Diluted 27.2M shares +23.5%

Income Statement

Label TTM Value / Value Unit Change %
Revenue from Contract with Customer, Excluding Assessed Tax 592K USD -93.8%
Research and Development Expense 76.8M USD -40.6%
General and Administrative Expense 40.9M USD -23%
Operating Income (Loss) -128M USD +26.1%
Net Income (Loss) Attributable to Parent -122M USD +27.8%
Earnings Per Share, Basic -5.09 USD/shares +69.6%
Earnings Per Share, Diluted -5.09 USD/shares +69.6%

Balance Sheet

Label TTM Value / Value Unit Change %
Cash and Cash Equivalents, at Carrying Value 34.4M USD -34.8%
Cash, Cash Equivalents, and Short-term Investments 110M USD -43.4%
Accounts Receivable, after Allowance for Credit Loss, Current 1.77M USD
Assets, Current 118M USD -42.2%
Property, Plant and Equipment, Net 4.51M USD -28.4%
Operating Lease, Right-of-Use Asset 8.82M USD -7.05%
Intangible Assets, Net (Excluding Goodwill) 0 USD -100%
Goodwill 0 USD -100%
Other Assets, Noncurrent 586K USD -12.1%
Assets 134M USD -42.6%
Contract with Customer, Liability, Current 0 USD -100%
Liabilities, Current 26.4M USD -49.2%
Contract with Customer, Liability, Noncurrent 0 USD -100%
Deferred Income Tax Liabilities, Net 0 USD -100%
Operating Lease, Liability, Noncurrent 10.7M USD -8.92%
Other Liabilities, Noncurrent 0 USD -100%
Liabilities 37.1M USD -41.8%
Accumulated Other Comprehensive Income (Loss), Net of Tax -690K USD +0.25%
Retained Earnings (Accumulated Deficit) -1.69B USD -7.78%
Stockholders' Equity Attributable to Parent 96.7M USD -42.9%
Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest 222M USD -44.4%
Liabilities and Equity 134M USD -42.6%

Popular Metrics

Label TTM Value / Value Unit Change %
Net Cash Provided by (Used in) Operating Activities -28.8M USD +21.6%
Net Cash Provided by (Used in) Financing Activities -11.4M USD -2576%
Net Cash Provided by (Used in) Investing Activities 45.4M USD +139%
Common Stock, Shares Authorized 600M shares 0%
Common Stock, Shares, Issued 26M shares -90.3%
Common Stock, Par or Stated Value Per Share 0 USD/shares 0%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect 5.29M USD
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents 34.4M USD -34.8%
Interest Paid, Excluding Capitalized Interest, Operating Activities 533K USD +0.06%
Deferred Tax Assets, Valuation Allowance 327M USD +9.48%
Deferred Tax Assets, Gross 329M USD +9.3%
Operating Lease, Liability 13M USD -7.64%
Depreciation 424K USD -40%
Payments to Acquire Property, Plant, and Equipment 35.6K USD -88%
Comprehensive Income (Loss), Net of Tax, Attributable to Parent -32.3M USD +9.52%
Lessee, Operating Lease, Liability, to be Paid 16.1M USD -11%
Property, Plant and Equipment, Gross 25.8M USD -11.9%
Operating Lease, Liability, Current 2.32M USD -1.25%
Lessee, Operating Lease, Liability, to be Paid, Year Two 3.56M USD +16.1%
Lessee, Operating Lease, Liability, to be Paid, Year One 3.47M USD +13.7%
Operating Lease, Weighted Average Discount Rate, Percent 0.09 pure 0%
Lessee, Operating Lease, Liability, Undiscounted Excess Amount 3.14M USD -22.5%
Lessee, Operating Lease, Liability, to be Paid, Year Three 2.96M USD -5.86%
Deferred Tax Assets, Operating Loss Carryforwards 236M USD +10.7%
Preferred Stock, Shares Issued 9 shares 0%
Preferred Stock, Shares Authorized 10M shares 0%
Unrecognized Tax Benefits 22.1M USD +4.61%
Lessee, Operating Lease, Liability, to be Paid, Year Four 2.31M USD -8.55%
Additional Paid in Capital 1.78B USD +2.84%
Preferred Stock, Shares Outstanding 9 shares 0%
Amortization of Intangible Assets 0 USD -100%
Deferred Tax Assets, Net of Valuation Allowance 1.99M USD -13.9%
Interest Expense 1.09M USD -13.3%
Preferred Stock, Par or Stated Value Per Share 0 USD/shares 0%